These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

80 related articles for article (PubMed ID: 17824050)

  • 1. [Primary hypercholesterolemia other than familial hypercholesterolemia and familial combined hyperlipidemia].
    Arai H
    Nihon Rinsho; 2007 Jul; 65 Suppl 7():321-5. PubMed ID: 17824050
    [No Abstract]   [Full Text] [Related]  

  • 2. Hyperlipidemia, dyslipoproteinemia and apolipoproteinopathia--classification and risk of atherosclerosis. Part 2: Hypercholesterolemia.
    Choluj B; Votruba T
    Acta Univ Carol Med (Praha); 1991; 37(3-4):106-15. PubMed ID: 1845465
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Polygenic hypercholesterolemia].
    Matsushima T; Teramoto T
    Ryoikibetsu Shokogun Shirizu; 1998; (19 Pt 2):104-7. PubMed ID: 9645019
    [No Abstract]   [Full Text] [Related]  

  • 4. [Lipid metabolism disorders: diagnosis and treatment. 3: Treatment goals--therapy groups--primary hyperlipidemias. Nationale Cholesterin-Initiative].
    Fortschr Med; 1991 May; 109(15):323-4, 325-6. PubMed ID: 1855759
    [No Abstract]   [Full Text] [Related]  

  • 5. [The effect of micronized fenofibrate on lipid parameters and fibrinogen in heterozygous familial hypercholesterolemia and familial combined hyperlipidemia].
    Ceska R; Sobra J; Kvasnicka J; Procházková R; Kvasilová M; Haas T
    Cas Lek Cesk; 1996 Jul; 135(13):413-6. PubMed ID: 8925538
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evidence that non-lipid cardiovascular risk factors are associated with high prevalence of coronary artery disease in patients with heterozygous familial hypercholesterolemia or familial combined hyperlipidemia.
    Skoumas I; Masoura C; Pitsavos C; Tousoulis D; Papadimitriou L; Aznaouridis K; Chrysohoou C; Giotsas N; Toutouza M; Tentolouris C; Antoniades C; Stefanadis C
    Int J Cardiol; 2007 Oct; 121(2):178-83. PubMed ID: 17188767
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Familial combined hyperlipidemia: controversial aspects of its diagnosis and pathogenesis.
    Aguilar Salinas CA; Zamora M; Gómez-Díaz RA; Mehta R; Gómez Pérez FJ; Rull JA
    Semin Vasc Med; 2004 May; 4(2):203-9. PubMed ID: 15478042
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Combined drug therapy--cholestyramine and compactin--for familial hypercholesterolemia.
    Yamamoto A; Yamamura T; Yokoyama S; Sudo H; Matsuzawa Y
    Int J Clin Pharmacol Ther Toxicol; 1984 Sep; 22(9):493-7. PubMed ID: 6500769
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Hypercholesterolemia in children and young adults: should screening be done?].
    Keller U
    Schweiz Med Wochenschr; 1995 Feb; 125(7):255-63. PubMed ID: 7878403
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Familial hypercholesterolemia (one form of familial type II hyperlipoproteinemia). A study of its biochemical, genetic and clinical presentation in childhood.
    Kwiterovich PO; Fredrickson DS; Levy RI
    J Clin Invest; 1974 May; 53(5):1237-49. PubMed ID: 4363406
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Possible relationship between overweightness and prevalence of hyperlipemia in the children of patients with heterozygote familial hypercholesterolemia and combined familial hyperlipemia].
    Jansen S; Zambrana JL; López Miranda J; Blanco A; Blanco J; Jiménez Perepérez JA; Espino A; Pérez Jiménez F
    Med Clin (Barc); 1995 Jun; 105(3):85-8. PubMed ID: 7603116
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Progress in the diagnosis of endocrine and metabolic disorders: hyperlipidemia].
    Yamashita S
    Rinsho Byori; 1995 Nov; 43(11):1120-7. PubMed ID: 8551675
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Polymorphism and peripheral levels of apolipoprotein(a) in polygenic hypercholesterolemia and combined hyperlipidemia.
    Shen GX; Mymin D; Dembinski T; Krahn A; Angel A
    Clin Invest Med; 1995 Feb; 18(1):33-41. PubMed ID: 7768064
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Familial combined hyperlipidemia].
    Sasaki J
    Nihon Rinsho; 1999 Dec; 57(12):2776-81. PubMed ID: 10638212
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Family study of primary hypercholesterolemia in school children--the Tsukuba Study].
    Yanagi H; Hamaguchi H; Shimakura Y; Hirano C; Takita H; Tsuchiya S; Yoshiwara C
    Nihon Koshu Eisei Zasshi; 1990 Aug; 37(8):585-92. PubMed ID: 2132386
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Clinical and biochemical features of atherosclerosis main risk factors in children of probands with primary hyperlipidemia].
    Alidzhanova KhG; Tvorogova MG; Rozhkova TA; Balakhonova TV; Vorob'eva LP; Masenko VP; Kukharchuk VV
    Ter Arkh; 1998; 70(1):19-23. PubMed ID: 9532645
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pediatric cholesterol screening: missed opportunities.
    Liacouras CA; Shamir R
    Isr J Med Sci; 1997 Oct; 33(10):659-62. PubMed ID: 9397139
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Drug therapy of hypercholesterolemia. Treatment of hypercholesterolemia in adults--a Norwegian therapeutic program 1988].
    Ose L; Blomhoff JP; Torsvik H
    Tidsskr Nor Laegeforen; 1989 Mar; 109(7-8):850-2. PubMed ID: 2705170
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Low postheparin plasma hepatic lipase activity in familial type IIa hyperlipoproteinemia.
    Nikkilä EA; Huttunen JK; Ehnholm C
    Ann Clin Res; 1976 Feb; 8(1):63-7. PubMed ID: 180867
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Ezetimibe treatment of pediatric patients with hypercholesterolemia.
    Clauss S; Wai KM; Kavey RE; Kuehl K
    J Pediatr; 2009 Jun; 154(6):869-72. PubMed ID: 19230898
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.